Pealkiri: 

HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis

Autorid: Uusküla A, Toompere K, Laisaar K, Rosenthal M, Pürjer M, Knellwolf A, Läärä E, Des Jarlais D
Väljaandja/tellija: BMJ Open
Märksõnad: HIV, teaduslik uurimistöö, rahvusvaheline koostöö
Välja antud: 2015
Tüüp: Teaduslik artikkel/kogumik
Viide: Uusküla A, Toompere K, Laisaar KT, et al. HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis. BMJ Open 2015;5(2):e006591.
Alamvaldkonnad:Tervisenäitajate siseriiklik ja rahvusvaheline võrdlus
Kirjeldus: To assess HIV/AIDS research productivity in the 27 countries of the European Union (EU), and the structural level factors associated with levels of HIV/AIDS research productivity.
A bibliometric analysis was conducted with systematic search methods used to locate HIV/AIDS research publications (period of 1 January 2002 to 31 December 2011; search databases: MEDLINE (Ovid, PubMed), EMBASE, ISI-Thomson Web of Science; no language restrictions).
The publication rate (number of HIV/AIDS research publications per million population in 10 years) and the rate of articles published in HIV/AIDS journals and selected journals with moderate to very high (IF >=3) 5-year impact factors were used as markers for HIV research productivity. A negative binomial regression model was fitted to assess the impact of structural level factors (sociodemographic, health, HIV prevalence and research/development indicators) associated with the variation in HIV research productivity.
The total numbers of HIV/AIDS research publications in 2002-2011 by country ranged from 7 to 9128 (median 319). The median publication rate (per million population in 10 years) was 45 (range 5-150) for all publications. Across all countries, 16% of the HIV/AIDS research was published in HIV/AIDS journals and 7% in selected journals with IF >=3. Indicators describing economic (gross domestic product), demographic (size of the population) and epidemiological (HIV prevalence) conditions as well as overall scientific activity (total research output) in a country were positively associated with HIV research productivity.
HIV research productivity varies noticeably across EU countries, and this variation is associated with recognisable structural factors.